Related Experiment Video
Updated: Mar 26, 2026
06:36
An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices
Published on: February 5, 2015
7.6K
Tumefactive Demyelinating Lesions in Multiple Sclerosis and Associated Disorders
Meredith C Frederick1,2, Michelle H Cameron3,4
1Department of Neurology, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, L226, Portland, OR, 97239, USA. Frederim@OHSU.edu.
Current Neurology and Neuroscience Reports
|February 6, 2016
Summary
Tumefactive demyelinating lesions are rare but challenging CNS conditions. This review covers their varied causes, diagnosis, and management in demyelinating diseases.
Area of Science:
- Neurology
- Neuroscience
- Radiology
Background:
- Tumefactive demyelinating lesions (TDLs) are uncommon manifestations of central nervous system (CNS) inflammatory demyelinating diseases.
- TDLs present diagnostic challenges due to their mimicry of tumors and abscesses, and their diverse underlying etiologies.
Purpose of the Study:
- To review recent literature on the clinical presentation, radiographic features, prognosis, and management of TDLs.
- To explore TDLs within the context of various demyelinating diseases, including multiple sclerosis and its variants.
Main Methods:
- Literature review of recent publications.
- Synthesis of information on clinical, radiographic, prognostic, and management aspects of TDLs.
Main Results:
- TDLs are associated with a spectrum of CNS idiopathic inflammatory demyelinating diseases.
- Diagnostic differentiation of TDLs requires careful consideration of clinical and imaging findings.
Conclusions:
- Understanding the heterogeneity of TDLs is crucial for accurate diagnosis and effective management.
- Further research is needed to refine diagnostic criteria and therapeutic strategies for TDLs.
Related Concept Videos
01:28Disorders of the Nervous Tissue
3.0K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
3.0K
01:15Parkinson's Disease: Overview
2.4K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.4K
01:24T Cell Types and Functions
3.2K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.2K
03:03Amyloid Fibrils
12.9K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
12.9K